Phys Act Nutr Search

CLOSE


Phys Act Nutr > Volume 29(2); 2025 > Article
Kim, Choi, Seo, Ka, and Park: Effect of exercise on the human gut microbiota in individuals with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

Abstract

[Purpose]

Obesity and its associated comorbidities, including chronic inflammation, pose significant public health challenges. Recent studies have suggested a link between obesity and gut microbial dysbiosis, with exercise emerging as a potential modulator of gut microbiota by enhancing microbial diversity and short-chain fatty acid (SCFA) production. However, the effects of exercise on the microbiome diversity and composition in overweight individuals or with obesity remain inconsistent.

[Methods]

This study systematically reviewed literature from PubMed, Embase, Cochrane Library, and ScienceDirect databases up to November 5, 2024, following PRISMA guidelines. Eleven studies were included in the systematic review, and four studies with quantitative data were analyzed using meta-analysis (Comprehensive Meta-Analysis software) and the ROB tool.

[Results]

The meta-analysis showed a statistically significant effect of exercise on beta diversity. The pooled effect size for Bray-Curtis dissimilarity was 4.56 (95% confidence interval (CI) [1.77, 11.80], Z = 3.14, P = 0.002). These findings suggest that exercise positively influences gut microbial structure in overweight individuals or with obesity.

[Conclusion]

Exercise may be a key component of lifestyle modification to modulate the gut microbiota and improve metabolic health in overweight individuals or with obesity. Future studies should evaluate the independent effects of fitness improvement and weight loss on gut microbial composition by employing multi-omics and metabolic pathway analyses to develop personalized obesity management strategies.

INTRODUCTION

Obesity is a complex, multifactorial disease associated with chronic conditions such as type 2 diabetes mellitus (T2DM), metabolic syndrome (MetS), and non-alcoholic fatty liver disease (NAFLD) [1,2]. As the prevalence of obesity continues to increase, it poses a significant public health challenge by increasing the global burden of the disease [3]. Recent research has highlighted the gut microbiota as a modifiable factor in regulating host metabolism and inflammation, offering new strategies for preventing and managing metabolic disorders [4,5].
Human gut microbiota plays a pivotal role in energy balance, hormone regulation, and immune function [6]. Dysbiosis, an imbalance in microbial composition, has been linked to obesity through mechanisms such as increased energy harvesting, disrupted gut barrier integrity, and chronic inflammation [7]. Individuals with obesity exhibit distinct gut microbiota profiles, characterized by a reduced microbial diversity and a higher Firmicutes-to-Bacteroidetes (F/B) ratio, which correlates with increased adiposity [8,9]. In Japanese and Korean populations, obese individuals show significantly lower alpha diversity and distinct beta diversity patterns than lean individuals, suggesting that both body mass index (BMI) and metabolic health status influence gut microbiota composition [10,11].
Diet and lifestyle strongly influence gut microbiota composition, surpassing the impact of genetic factors [12]. A Western-style diet, high in fat and refined carbohydrates, promotes gut microbiota imbalance, reducing the beneficial microbes and overall microbial diversity [13]. These changes may drive epigenetic modifications, such as alterations in DNA methylation and histone modifications, further exacerbating gut dysbiosis [14]. Moreover, lifestyle changes influence microbial diversity at the population level. For instance, urban populations exhibit lower alpha diversity than traditional hunter-gatherer populations, reflecting the impact of modern lifestyles on gut microbiota [15].
Among lifestyle factors, exercise is an effective intervention for improving metabolic health and gut microbiota composition. Exercise promotes the growth of short-chain fatty acid (SCFA)-producing bacteria [16-18]. Although the overall benefits of these exercises have been well documented, results regarding their impact on the gut microbiota are inconsistent. Six weeks of aerobic exercise increased the abundance of SCFA-producing bacteria such as Faecalibacterium, Roseburia, and Lachnospira in non-obese individuals; however, no similar effect was observed in obese individuals [19]. Although some studies have shown increased microbial diversity after exercise, others have reported minimal changes or differing responses depending on the intervention type and population characteristics [20].
Despite the growing interest in the relationship between exercise and gut microbiota, most existing studies have focused on short-term interventions or specific populations, with limited synthesis of their overall impact. The present study provides a comprehensive review and meta-analysis that integrates the findings from various exercise interventions, highlighting their effects on both alpha and beta diversity in overweight and obese populations. By synthesizing data from multiple studies, this study offers a clearer understanding of exercise-induced changes in gut microbiota diversity, addresses inconsistencies in the current literature, and provides practical insights for clinical applications.

METHODS

Selection and eligibility

This study followed the PRISMA guidelines to ensure a transparent and systematic approach to selecting relevant studies. The eligibility criteria were established based on the PICO framework. Participants included individuals classified as overweight or obese, defined as a BMI ≥ 25 kg/m2 or waist circumference (WC) ≥ 90 cm. The intervention of interest was exercise, whereas the comparison group consisted of non-exercise controls, alternative interventions, or varying exercise intensities. The primary outcome was gut microbiota-related changes, focusing on microbial diversity and specific taxonomic alterations. Studies without control groups were considered eligible if they compared different exercise intensities. The review protocol was not registered in PROSPERO or any other public database because of the limited number of eligible studies and the narrow scope of this review.

Search strategies and selection process

A comprehensive literature search was conducted in four databases, PubMed, Embase, Cochrane Library, and Web of Science, covering studies published up to November 5, 2024. The search was limited to randomized controlled trials (RCTs) conducted on human subjects. Keywords were carefully selected to identify relevant studies by combining terms related to metabolic disorders, gut microbiota, and exercise. The primary search terms included: (“diabetes” OR “T2DM” OR “type 2 diabetes” OR “obesity” OR “metabolic syndrome” OR “hypertension” OR “MetS”) AND (“gut microbiota” OR “microbiome” OR “intestinal permeability” OR “gut barrier function” OR “Zonulin”) AND (“physical activity” OR “exercise” OR “HIIT” OR “MICT” OR “aerobic training”).
Studies were excluded if they involved participants who were not overweight or obese, focused on specific diseases, such as celiac disease or coronary artery disease, or lacked a clear exercise intervention. Studies involving pharmacological or nutritional interventions were excluded to prevent potential confounding effects. Abstract-only publications without full-text access were excluded owing to insufficient information. During the eligibility phase, studies that mentioned the gut microbiota but did not provide descriptive outcome data were excluded from the analysis.

Data extraction

Data were extracted by a PhD researcher specializing in exercise and nutrition. The extracted information included participant characteristics (e.g., age and health status), intervention type, and gut microbiota outcomes. The extracted data were systematically organized using EndNote (version 21.4) for reference management. Outcomes related to the gut microbiota were categorized into alpha and beta diversity measures and changes in specific microbial taxa.

Data analysis

Quantitative synthesis was performed for studies that provided sufficient data for the effect size calculation. Comprehensive Meta-Analysis (CMA, version 4) software was used for statistical analysis. The effect sizes were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Given the expected heterogeneity among the studies, a random-effects model was applied to ensure a more conservative estimate of the intervention effects. Heterogeneity was assessed using the I² statistic with thresholds of 25%, 50%, and 75% representing low, moderate, and high heterogeneity, respectively.

Risk-of-bias assessment

The risk-of-bias of the included studies was assessed using Cochrane’s Risk of Bias 2 (RoB 2) tool. This tool evaluates potential bias across five key domains: randomization process, deviations from intended interventions, missing outcome data, outcome measurement, and selection of the reported result. Each domain was categorized as low-, moderate-, or high-risk. The assessments were performed independently by three reviewers, and any discrepancies were resolved through a consensus process to ensure accuracy and consistency. This multi-reviewer approach minimized subjectivity and improved the reliability of the evaluations. Only studies that reported comparable and quantifiable metrics of microbial beta diversity, specifically Bray-Curtis dissimilarity, were included.

RESULTS

Systematic review of selected studies

A total of 777 records were initially identified through the database search. After removing 212 duplicate records, 565 remained for further screening. Following the screening of titles and abstracts, 295 articles were selected for full-text evaluation based on predefined eligibility criteria. Among these, 13 studies were initially considered eligible; however, two studies were excluded owing to insufficient outcome data and pharmacological treatment, resulting in the final inclusion of 11 RCTs in the systematic review. The detailed study selection process is shown in Figure 1.
The 11 studies included collectively involved 319 participants, with individual study sample sizes ranging from 12 to 85. The participants included overweight and obese individuals across various age groups ranging from children to older adults. Except for one study [21], which involved diabetic patients with a mean waist circumference of 109 cm (indicative of central obesity), all other studies reported a mean BMI exceeding 25 kg/m2. Exercise interventions were mandatory in all the included studies, whereas the control groups varied across studies and consisted of sedentary groups, dietary interventions, or alternative exercise intensities. One study employed either moderate-intensity continuous training or high-intensity interval training combining aerobic and resistance components (C-MICT and C-HIIT). A detailed summary of the study characteristics is presented in Table 1.

Meta-analysis of the microbiota diversity

Gut microbiome outcomes were assessed using 16S rRNA gene sequencing or shotgun metagenomics, focusing on changes in alpha diversity (e.g., Shannon index) and beta diversity (e.g., Weighted UniFrac and Bray-Curtis dissimilarity), as well as specific microbial taxa alterations. The included studies were further categorized for quantitative evaluation based on their reporting of alpha and beta diversities. Although various measures of alpha and beta diversities were reported across studies, only Bray-Curtis dissimilarity was presented consistently enough to be included in the meta-analysis. The number of studies that reported alpha diversity and weighted UniFrac values in a comparable manner was insufficient for inclusion in the meta-analysis.
Risk-of-bias assessments were performed for all included studies using the RoB 2 tool. All five domains—D1: bias arising from the randomization process, D2: deviations from intended interventions, D3: missing outcome data, D4: measurement of the outcome, and D5: selection of the reported results—were rated as low-risk across all included studies, based on consensus among three independent reviewers. Specifically, D1 was rated as low-risk because all studies provided a clearly described randomization process. For D2, although blinding is inherently difficult in exercise-based trials and some concerns were initially raised, no major deviations from the intended interventions were identified, and the domain was ultimately judged to be low-risk. D3 was rated as low-risk, as all studies utilized stool-based analyses (16S rRNA or shotgun metagenomics), thus minimizing the possibility of missing data. D4 was also rated low owing to the consistency and comparability of outcome measurement methods across studies. Finally, D5 was rated as low-risk because both significant and non-significant results were transparently reported without evidence of selective outcome reporting. Figures 2 and 3 present the risk-of-bias assessments of the meta-analysis outcomes.
The meta-analysis revealed significant improvements in microbiota diversity in participants who underwent exercise interventions compared with those in the control groups. The results based on Bray-Curtis dissimilarity demonstrated consistent patterns of enhanced microbial diversity. The pooled effect size was 4.56, with a moderate level of heterogeneity observed (I² = 48.2%, τ² = 0.444) (Figure 4).

DISCUSSION

Overall effect of exercise intervention on microbiota diversity

Among the 10 studies analyzing beta diversity, six [21-26] reported significant changes in beta diversity following exercise intervention between 2 and 6 months. One study [27] reported exercise-induced changes in beta diversity but did not provide statistical significance.
In contrast, three studies [28-30] did not identify any significant differences in beta diversity after exercise interventions. Couvert et al. compared isoenergetic HIIT programs performed at the same intensity and frequency during running and cycling [29]. Therefore, the absence of significant differences between the two groups may result from the matched exercise conditions. A study comparing a group performing HIIT alone with another group performing HIIT combined with intermittent fasting found no relative differences in beta diversity [28]. No differences were observed in the beta diversity clustering based on either Unweighted or Weighted UniFrac analyses [30]. However, functional metabolite analysis based on KEGG pathways revealed significant segregation between HOMA-IR responders and non-responders, as shown in the beta diversity NMDS plot using Bray-Curtis dissimilarity.
Changes in beta diversity were sometimes minimal, depending on the intervention type and study duration. For example, both weight loss strategies (exercise + diet vs. diet only) led to a 10% reduction in body weight with similar directional changes in beta diversity [22]. In the Weighted UniFrac, greater distances were observed in the exercise group than in the non-exercise control group [25]. No significant changes were observed in the Weighted UniFrac and Bray-Curtis indices, whereas a significant difference in beta diversity was detected using the Euclidean distance [26]. In addition, the Bray-Curtis dissimilarity index remained consistently high. Although heterogeneity decreased after the exercise intervention, the index remained higher than that of the control group [25]. These results reinforce the previous findings of a systematic review [31], which found distinct beta diversity separation in animal models, but reported inconsistent patterns in humans depending on disease status. We observed a consistent pattern of a significantly greater Bray-Curtis dissimilarity distance in the exercise intervention group than in the control group among overweight/obese individuals [23-25]. The meta-analytic findings regarding Bray-Curtis dissimilarity are illustrated in Figure 4.
Regarding alpha diversity, the findings have been inconsistent; although most studies reported no significant effect of exercise, two studies reported a significant increase [24,25]. A previous systematic review of healthy individuals reported an association between cardiac fitness and alpha diversity [32]. Similarly, a significant correlation between VO2 max and Shannon diversity values was observed [23].
Additionally, a positive correlation between the Shannon index and fat mass reduction has been reported, suggesting a potential link between exercise-induced changes in body composition and microbial diversity [29]. Nonetheless, as previously noted, we were unable to identify a consistent relationship between increases in alpha diversity and exercise effects or exercise-mediated factors such as improvements in physical fitness or reductions in body weight. These results may be attributed to the fact that previous studies have primarily focused on comparing the effects relative to a control group. Consequently, in studies that examined differences based on exercise intensity, no significant changes in alpha diversity have been reported between exercise types. However, these studies may have overlooked meaningful changes in the effects of exercise in individual groups.
Overall, these results suggest that exercise induces short-term changes in the beta diversity in overweight and obese individuals. Supporting this, a large-scale meta-analysis of 3,329 samples found that obese individuals exhibited significantly lower beta diversity than healthy controls, with a more homogeneous gut microbiota composition [33]. Our findings align with this, suggesting that exercise interventions can effectively enhance microbial diversity and counteract the monotonous microbial patterns associated with obesity. However, improvements in alpha diversity have not been consistently observed. This finding is inconsistent with human studies that have reported that exercise enhances alpha diversity. One possible explanation is that this observation may be attributable to the fact that our study was limited to overweight and obese populations. Although reduced microbial diversity is often associated with dysbiosis, various indicators have been employed to assess this condition, and no single metric has been consistently recognized as the universal gold standard. Nevertheless, our findings confirmed that exercise interventions serve as a strategy to modulate beta diversity in obese individuals, promoting more phylogenetically distinct and diverse microbial compositions across individuals.

Changes in microbiota

The overall changes in microbiota following exercise intervention are presented in Table 1. High-intensity exercises exceeding 80% HR and sprint-based exhaustive exercise interventions commonly result in an increase in bacteria of the order Lachnospirales, particularly within the Clostridium citroniae, Lachnospiraceae family, and Lachnospira genus [21,30,34].
In addition, moderate-intensity exercise training led to an increase in Lachnospira eligens [21]. At the species level, Roseburia, which belongs to the Lachnospirales order, also increased following exercise [26,27]. Blautia, a butyrate-producing genus, has been associated with increased visceral fat when its abundance is reduced [35], whereas it has been associated with obesity and metabolic disorder alleviation [36]. However, its response to exercise remains inconsistent. The relative abundance of children with obesity increased following an exercise intervention [27]. In contrast, a decrease was observed after moderate-intensity sprint interval training [34]. Considering the short intervention period (2 weeks), these findings suggest that long-term dietary patterns can influence changes in SCFA levels within subjects and that these changes may vary depending on factors such as the subject’s growth phase. Given that these factors may lead to different outcomes in children with obesity, distinguishing growing adolescents from separate populations is essential.
Regarding the order Oscillospirales, classified under Firmicutes, the changes observed following the exercise interventions were primarily driven by members of the Ruminococcaceae family. Specifically, after exercise intervention, higher abundances of Faecalibacterium prausnitzii, Clostridium leptum, and Ruminococcus bromii have been reported [21,34].
Differences in the exercise intensity were observed. The relative abundance of Ruminococcus bromii increased following C-HIIT, whereas after C-MICT, the relative abundance of Faecalibacterium prausnitzii within the Ruminococcaceae family increased [21].
Similarly, only MICT showed a trend toward an increased relative abundance of the genus Faecalibacterium [34]. Faecalibacterium is a butyrate-producing bacterium with anti-inflammatory properties that decreases pro-inflammatory cytokine levels, enhances intestinal barrier integrity, and potentially alleviates inflammatory bowel disease [37,38]. Furthermore, its beneficial effects extend to metabolic disorders including obesity and T2DM [37,39]. These findings highlight that the gut microbiota composition may exhibit differential responses to exercise intensity at a finer taxonomic resolution within the same family. Although variations in the relative abundance of microbes were detected between C-MICT and C-HIIT, no significant differences were found in the overall production of SCFA [21].
Based on a comparison of Carbohydrate-Active Enzymes (CAZy), both Ruminococcaceae and Lachnospiraceae harbor a greater number of glycoside hydrolases (GH) than Clostridiaceae, facilitating the more efficient degradation of complex carbohydrates [40]. Notably, Lachnospiraceae exhibited a significantly higher abundance of ATP-binding cassette (ABC) transporter genes.
Firmicutes was the most dominant phylum in the gut bacterial composition, with a highly variable species level composition. Our findings indicate that, whereas some studies reported an increase in Lachnospiraceae and Ruminococcaceae, which tended to increase within Firmicutes after exercise, Lachnospiraceae consistently showed a greater and more frequent increase across studies. Exceptionally, an increase in members of the Lachnospiraceae family and a reduction in species belonging to the Ruminococcaceae family were observed at the 1-month time point of weight loss, both in exercise- and diet-induced interventions, as well as in the diet-only group [22]. These results suggest that although exercise intervention is generally beneficial for host energy metabolism, as it can promote an increase or decrease in SCFA-producing bacteria within a broader framework, its effects do not always follow a consistent pattern.
Several studies have reported changes in the Bacteroidetes phylum after exercise. A relative increase in the abundance of Coprobacter, Rikenellaceae, and Bacteroidetes was observed after exercise [29,30,34]. A significant increase in Bacteroidetes was detected in the group that underwent intermittent fasting alone, whereas a similar increasing trend was noted in the group that underwent combined intermittent fasting and exercise, although the difference was not statistically significant (P > 0.05) [28]. In contrast, in a study in which Alistipes shahii showed a relative decrease, HIIT in patients with T2DM led to significant improvements in whole-body insulin sensitivity (Matsuda Index) among those with improved insulin resistance (HOMA-IR) [30]. However, except for the resting heart rate, no changes were observed in BMI or other clinical markers.
Similarly, we hypothesized that excess energy produced by Firmicutes could be alleviated through exercise. However, our findings on the Firmicutes/Bacteroidetes (F/B) ratio did not always align with our expectations. Although both the F/B ratio and its relationship with obesity are multifactorial indicators [41,42], only one study [34] reported this ratio in the context of exercise. This inconsistency may result from the absence of dramatic weight loss following interventions in the selected studies. Except for one study that reported a body weight reduction of approximately 10% [22], the interventions in the other reviewed studies did not lead to dramatic weight loss, despite some achieving statistically significant but modest weight reductions.
Furthermore, exercise is a promising strategy for increasing SCFA production, although its effects can be superimposed by well-mediated interventions such as the Mediterranean diet or pharmacological treatments for diabetes. The Mediterranean diet increases beneficial bacteria to appropriate amounts [43], whereas drug-based interventions improve the F/B ratio, eliciting similar effects on the gut microbiota [44]. These overlapping effects complicate the attribution of changes in microbiota to exercise alone. Nevertheless, both studies reported that exercise and weight loss significantly improved physical fitness, promoted SCFA-producing bacteria, and contributed to the favorable modulation of the F/B ratio. Collectively, these findings suggest that exercise, as a broad-acting intervention, may contribute to improvements in both host metabolic health and gut microbiota composition. However, its independent effects should be interpreted with caution because of the potential confounding influence of diet and medication (e.g., metformin and GLP-1 receptor agonists).
Excluding the changes in Firmicutes and Bacteroidetes, our studies consistently emphasized the benefits associated with the expression of SCFA-producing bacteria. However, the expected microbial shifts in the specific target taxa were not consistently observed. A representative example of this is Akkermansia. Akkermansia, a beneficial gut bacterium belonging to the phylum Verrucomicrobia, enhances the intestinal mucosal barrier and exerts anti-inflammatory effects [45,46]. For instance, its abundance increased significantly following moderate-intensity exercise compared to high-intensity exercise [21]. Although these levels remained higher than those in the non-responder group, a reduction was observed [30]. Similarly, no significant changes in the relative abundance have been reported [34]. Changes in the relative abundance of Akkermansia were positively correlated with changes in visceral fat mass [29]. Nevertheless, a causal relationship indicating that high-intensity training directly increased Akkermansia abundance was not observed. Such inconsistencies may stem from methodological heterogeneity across studies, including differences in statistical approaches, a focus on between-group versus within-subject comparisons, and variations in control group characteristics. Taken together, these results indicate that in the case of microbial taxa, particularly species such as Akkermansia, relative changes can vary in direction depending on the baseline abundance levels.
Although gut microbiota cannot be definitively identified as the primary cause of obesity, modulation of its composition continues to be regarded as a key therapeutic strategy. Whether beneficial bacteria should be targeted at the species level or administered as part of a multi-strain cocktail remains an open question [47]. Therefore, when aiming to modulate the gut microbiota through natural interventions such as exercise, rather than targeted treatments such as prebiotics, it is necessary to account for the heterogeneity of microbial responses and individual health characteristics.
Given the variability in the F/B ratio across obese populations, which is largely influenced by individual characteristics and environmental factors, improved taxonomic markers are needed for a more accurate assessment of obesity-related dysbiosis [41]. Reliance solely on F/B ratio may be insufficient for guiding obesity management strategies. Therefore, multiple microbial markers should be evaluated. Although weight loss-induced changes in F/B ratio and SCFA expression are generally associated with improvements in gut health, these effects vary significantly among individuals. The question remains as to whether gut microbiota-related benefits stem primarily from fasting-induced weight loss or exercise-mediated metabolic improvements. Therefore, individual characteristics, such as baseline fitness level, abdominal adiposity, and total fat mass, should be carefully considered as they may significantly influence the gut microbiota composition and its metabolic consequences.

Alpha and beta Diversity: interpretation

Our meta-analysis demonstrated a significant increase in beta diversity (Bray-Curtis dissimilarity) following exercise intervention, indicating that physical activity may lead to greater microbial differentiation among individuals. Although several individual studies have reported changes in alpha diversity, including increases in Shannon and Simpson indices, inconsistent reporting formats and methodological variability have prevented quantitative synthesis. Consequently, our meta-analysis focused exclusively on beta diversity using Bray-Curtis dissimilarity. The observed increase in beta diversity suggests greater inter-individual microbial differentiation following exercise. However, the absence of a meta-analysis of alpha diversity limited our ability to assess within-individual richness or evenness, thereby moderating the overall strength of our conclusions.

Limitations and further research

One limitation of this study is that it relied solely on data from published articles and supplementary materials. To minimize the risk of overinterpretation, we reported effect sizes based exclusively on between-group comparisons with the control groups. Although some studies reported significant within-subject changes, they were not included in the meta-analysis to maintain methodological rigor and ensure a more conservative interpretation of the findings. In line with this limitation, the small number of eligible studies precluded meta-regression analyses based on intervention frequency, exercise modality, or participant characteristics. Only four studies have provided comparable and quantifiable data on microbial beta diversity.
Lachnospirales and members of the Ruminococcaceae family belong to the phylum Firmicutes, and although their abundance increases following exercise, their roles are not always beneficial, particularly when considered in the context of obesity-related elevations in the Firmicutes/Bacteroidetes (F/B) ratio and energy surplus. Nonetheless, their potential advantages are often highlighted owing to their involvement in SCFA production and associated mechanisms.
In our review, we sought to identify consistent patterns, such as sustained associations between specific microbial taxa and improved metabolic outcomes (e.g., fat reduction, insulin sensitivity, and KEGG pathway activation); however, no such convergent responses were observed. This limitation may be attributed to the heterogeneity in intervention duration, exercise modality, and the presence or absence of underlying metabolic conditions, despite the consistent inclusion of overweight or obese individuals across studies. In addition, some key variables, including functional outputs such as KEGG pathway data, were not assessed in several studies, further limiting cross-study comparisons.
Although many existing reviews emphasize the general benefits of exercise, to the best of our knowledge, very few have specifically focused on overweight or obese individuals. Most previous studies have either combined human and animal data or included heterogeneous populations without stratification by weight status. In contrast, the strength of this review lies in its exclusive focus on overweight and obese individuals. However, one limitation is that many of the included studies did not report significant weight loss following the intervention, which somewhat constrained our ability to draw distinct conclusions regarding the weight-independent effects of exercise.
The human gut microbiome is highly individualized and is influenced by various factors, including physiology, environment, and genetics [48,49]. Although all studies included overweight or obese participants, this does not necessarily confirm that all measures of the gut microbiome composition reflect a consistent state of dysbiosis.
In addition to exercise, prebiotics and fecal microbiota transplantation (FMT) have been proposed as promising strategies for modulating gut microbiota in obesity management. However, the underlying mechanisms by which these interventions influence host metabolism remain poorly understood, and there is a lack of conclusive evidence linking specific microbial species to the direct regulation of obesity [4]. Future studies should focus on monitoring key microbial markers related to F/B ratio control and conducting functional analyses of metabolic pathways (e.g., Kyoto Encyclopedia of Genes and Genomes pathway) to better understand these interactions.
To advance this field, future research should explore the combined effects of physical fitness improvement, weight loss, and body fat reduction on the expression and metabolic activity of key gut microorganisms. Personalized intervention strategies that integrate exercise, prebiotics, and other dietary approaches tailored to individual microbiota profiles could serve as a foundation for precision medicine. Such an approach could help address the significant variability in gut microbiota responses and provide more targeted solutions for obesity management.

CONCLUSION

In conclusion, exercise may influence the gut microbiota composition in overweight and obese individuals, particularly by modulating specific SCFA-producing taxa such as members of the Lachnospirales family. Although the changes in alpha diversity were inconsistent, exercise was associated with observable alterations in beta diversity, suggesting a potential shift in the overall community structure. These findings highlight the potential of exercise to reshape the gut microbial composition, although interpretations of specific taxonomic responses should be made cautiously owing to variability across studies.

Acknowledgments

This study was supported by a Korea University Grant. This study was supported by the Ministry of Education of the Republic of Korea and National Research Foundation of Korea (NRF-2021S1A5A2A01068145).
The authors have no financial, consultant, institutional, or other relationships that might lead to bias or conflict of interest.

Figure 1.

Flow diagram of process for the systematic review.

The selection process for studies included in this systematic review was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
pan-2025-0014f1.jpg
Figure 2.

Weighted bar of risk-of-bias assessment.

This plot summarizes the distribution of risk judgments (low, some concerns, high) across all domains using the ROB 2 tool.
pan-2025-0014f2.jpg
Figure 3.

Traffic light plot of risk-of-bias assessment.

Each row represents an individual study, with color-coded judgments for each domain assessed according to the ROB 2 tool.
pan-2025-0014f3.jpg
Figure 4.

Meta-analysis of Bray-Curtis dissimilarity.

A significant difference in microbial community composition was observed between the intervention and control groups, with greater Bray-Curtis distances in the exercise intervention group. The pooled effect size was 4.56 (95% CI [1.77, 11.80]), with a Z-value of 3.14 (P = 0.002). Moderate heterogeneity was observed, with an I² value of 48.2%, τ² = 0.444, and a Q-value of 5.793 (P = 0.122).
pan-2025-0014f4.jpg
Table 1.
Summary of the effects of different exercise types on gut microbiota diversity and related microbial taxa changes
Study Participant (n) Intervention Duration Comparison Measurement Microbiota diversity changes Taxa changes
Beals 2023 [22] Obesity and prediabetes (15) 10% Weight loss by Caloric restriction + Exercise; AR + HIIT + RT 5 months 10% Weight loss by caloric restriction V4 region of the 16S rRNA gene • No significant differences in Alpha & Beta diversity • Similar ASV changes were observed at the 1-month weight loss point in both interventions
• Significant effect in Beta diversity (Weighted UniFrac) was observed in both interventions
Dupuit 2022 [23] Postmenopausal women with overweight or obesity (17) HIIT + RT 12 weeks Control V4 region of the 16S rRNA gene • No significant differences in Alpha diversity N/A
• Significant differences in Beta diversity (Bray-Curtis)
Couvert 2024 [29] Overweight or obesity (16) HIIT RUN & BIKE 12 weeks Self V4 region of the 16S rRNA gene • No significant differences in Alpha & Beta diversity • The abundances of Rikenellaceae, Clostridiaceae, and Actinomycetaceae increased after both exercise intervention
Torquati 2023 [21] T2DM (12) C-MICT 8 weeks C-HIIT 16S rRNA • No significant differences in Alpha diversity Significant differences in Beta diversity (Euclidean distance) • The C-MICT group exhibited a higher abundance of Bifidobacterium genus, Massiliaceae spp., Escherichia genus, Akkermansia municiphila, Lachnospira eligens, Clostridium leptum, Faecalibacterium prausnitzii, Enterococcus spp., Agathobaculum spp., and Anaeromassilibacillus spp.
• The C-HIIT group exhibited a higher abundance of Erysipelotrichales order, Methanobrevibacter smithii, Ruminococcus bromii, Clostridium citroniae, and Nagativibacillus spp.
Motiani 2020 [34] Overweight with prediabetes or T2DM (18) MICT 2 weeks SIT V3-V4 region of the 16S rRNA gene • No significant differences in Alpha diversity • In both SIT and MICT, the F/B ratio was reduced, the relative abundance of the Bacteroidetes phylum increased, and Blautia spp. and Clostridium spp. decreased
• A higher abundance of Veillonella genus was observed in MICT, while Lachnospira genus showed a higher abundance in SIT
Quiroga 2020 [27] Obese children (29) Strength and endurance training 12 weeks Control V3-V4 region of the 16S rRNA gene • Exercise group showed similar Beta diversity (PCoA) to healthy children. • Blautia, Dialister, Roseburia increased in exercise intervention, lead to healthy children profile
Wang 2024 [24] Overweight with prediabetes (39) HIIT 3 sessions per week 12 weeks Sedentary control Shotgun metagenomics • Significant increased fungal Alpha diversity (Shannon index) & Beta diversity (Bray-Curtis) • In the exercise group, the abundance of Verticillium, Chloridium, Iodophanus, Monosporascus, Beauveria, Ceratocystis, and Bipolaris increased
• Verticillium and Bipolaris were positively associated with insulin sensitivity, as indicated by fasting insulin levels and HOMA-IR.
Liu 2020 [30] Overweight with prediabetes, categorized by HOMA-IR response (20) HIIT 3 sessions per week 12 weeks Non-responder Shotgun metagenomics • No significant differences in alpha and beta diversity • In responders, the relative abundance of Lachnospiraceae and Streptococcus mitis increased, while that of Alistipes shahii decreased.
• Significant exercise-induced changes were identified in the NMDS plot of functional alterations and divergent pathway enrichment in responders
• After 12 weeks of exercise training, the NMDS plot in non-responders showed greater similarity to that of the sedentary controls
Batitucci 2024 [28] Obese adult women with sedentary lifestyle (36) HIIT and IF + HIIT 8 weeks Intermittent fasting V2-V5 region of the 16S rRNA gene • No significant differences in Alpha diversity & Beta diversity • In the intermittent fasting group, the relative abundance of Bacteroidetes increased
Kern 2020 [25] Physically inactive overweight or obesity (85) Bike commute, Moderate intensity exercise, Vigorous intensity exercise 6 months Control V4 region of the 16S rRNA gene • Significant differences in Alpha diversity (Shannon index) between VIG and CON at 3-month point. N/A
Significant differences in Beta diversity (Bray-Curits) BIKE, MOD and VIG compared CON
Cullen 2024 [26] Sedentary adults with overweight or obesity (32) RT 6 weeks Control V4 region of the 16S rRNA gene • Significant group x week interaction effects in Alpha diversity (Shannon index, Simpson index and Simpson evenness) Beta diversity (Euclidean distance) • Roseburia increased following the resistance training.

16S rRNA: 16S Ribosomal RNA, AR: Aerobic Exercise, ASVs: Amplicon Sequence Variants, C-MICT: Combined Moderate-Intensity Continuous Training, C-HIIT: Combined High-Intensity Interval Training, CON: Control group, EX: Exercise, F/B ratio: Firmicutes/Bacteroidetes Ratio, HIIT: High-Intensity Interval Training, HOMA-IR: Homeostatic Model Assessment for Insulin Resistance, HR peak: Peak Heart Rate, HRmax: Maximum Heart Rate, HRR: Heart Rate Recovery, IF: Intermittent Fasting, kJ: Kilojoule, MOD: Moderate Intensity group, PCoA: Principal Coordinates Analysis, Rep: Repetition, RPE: Rating of Perceived Exertion, RT: Resistance Training, SIT: Sprint Interval Training, T2DM: Type 2 Diabetes Mellitus, VO2 peak: Peak Volume of Oxygen Consumption, VIG: Vigorous Intensity group

REFERENCES

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-7.
crossref pmid pdf
2. Geng J, Ni Q, Sun W, Li L, Feng X. The links between gut microbiota and obesity and obesity related diseases. Biomed Pharmacother 2022;147:112678.
crossref pmid
3. Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, Dalton BE, Duprey J, Cruz JA, Hagins H, Lindstedt PA, Aali A, Abate YH, Abate MD, Abbasian M, Abbasi-Kangevari Z, Abbasi-Kangevari M, Abd ElHafeez S, Abd-Rabu R, Abdulah DM, Abdullah AYM, Abedi V, Abidi H, Aboagye RG, Abolhassani H, Abu-Gharbieh E, Abu-Zaid A, Adane TD, Adane DE, Addo IY, Adegboye OA, Adekanmbi V, Adepoju AV, Adnani QES, Afolabi RF, Agarwal G, Aghdam ZB, Agudelo-Botero M, Aguilera Arriagada CE, Agyemang-Duah W, Ahinkorah BO, Ahmad D, Ahmad R, Ahmad S, Ahmad A, Ahmadi A, Ahmadi K, Ahmed A, Ahmed A, Ahmed LA, Ahmed SA, Ajami M, Akinyemi RO, Al Hamad H, Al Hasan SM, Al-Ahdal TMA, Alalwan TA, Al-Aly Z, AlBataineh MT, Alcalde-Rabanal JE, Alemi S, Ali H, Alinia T, Aljunid SM, Almustanyir S, Al-Raddadi RM, Alvis-Guzman N, Amare F, Ameyaw EK, Amiri S, Amusa GA, Andrei CL, Anjana RM, Ansar A, Ansari G, Ansari-Moghaddam A, Anyasodor AE, Arabloo J, Aravkin AY, Areda D, Arifin H, Arkew M, Armocida B, Ärnlöv J, Artamonov AA, Arulappan J, Aruleba RT, Arumugam A, Aryan Z, Asemu MT, Asghari-Jafarabadi M, Askari E, Asmelash D, Astell-Burt T, Athar M, Athari SS, Atout MMdW, Avila-Burgos L, Awaisu A, Azadnajafabad S, B DB, Babamohamadi H, Badar M, Badawi A, Badiye AD, Baghcheghi N, Bagheri N, Bagherieh S, Bah S, Bahadory S, Bai R, Baig AA, Baltatu OC, Baradaran HR, Barchitta M, Bardhan M, Barengo NC, Bärnighausen TW, Barone MTU, Barone-Adesi F, Barrow A, Bashiri H, Basiru A, Basu S, Basu S, Batiha A-MM, Batra K, Bayih MT, Bayileyegn NS, Behnoush AH, Bekele AB, Belete MA, Belgaumi UI, Belo L, Bennett DA, Bensenor IM, Berhe K, Berhie AY, Bhaskar S, Bhat AN, Bhatti JS, Bikbov B, Bilal F, Bintoro BS, Bitaraf S, Bitra VR, Bjegovic-Mikanovic V, Bodolica V, Boloor A, Brauer M, Brazo-Sayavera J, Brenner H, Butt ZA, Calina D, Campos LA, Campos-Nonato IR, Cao Y, Cao C, Car J, Carvalho M, Castañeda-Orjuela CA, Catalá-López F, Cerin E, Chadwick J, Chandrasekar EK, Chanie GS, Charan J, Chattu VK, Chauhan K, Cheema HA, Chekol Abebe E, Chen S, Cherbuin N, Chichagi F, Chidambaram SB, Cho WCS, Choudhari SG, Chowdhury R, Chowdhury EK, Chu D-T, Chukwu IS, Chung S-C, Coberly K, Columbus A, Contreras D, Cousin E, Criqui MH, Cruz-Martins N, Cuschieri S, Dabo B, Dadras O, Dai X, Damasceno AAM, Dandona R, Dandona L, Das S, Dascalu AM, Dash NR, Dashti M, Dávila-Cervantes CA, De la Cruz-Góngora V, Debele GR, Delpasand K, Demisse FW, Demissie GD, Deng X, Denova-Gutiérrez E, Deo SV, Dervišević E, Desai HD, Desale AT, Dessie AM, Desta F, Dewan SMR, Dey S, Dhama K, Dhimal M, Diao N, Diaz D, Dinu M, Diress M, Djalalinia S, Doan LP, Dongarwar D, dos Santos Figueiredo FW, Duncan BB, Dutta S, Dziedzic AM, Edinur HA, Ekholuenetale M, Ekundayo TC, Elgendy IY, Elhadi M, El-Huneidi W, Elmeligy OAA, Elmonem MA, Endeshaw D, Esayas HL, Eshetu HB, Etaee F, Fadhil I, Fagbamigbe AF, Fahim A, Falahi S, Faris MEM, Farrokhpour H, Farzadfar F, Fatehizadeh A, Fazli G, Feng X, Ferede TY, Fischer F, Flood D, Forouhari A, Foroumadi R, Foroutan Koudehi M, Gaidhane AM, Gaihre S, Gaipov A, Galali Y, Ganesan B, Garcia-Gordillo MA, Gautam RK, Gebrehiwot M, Gebrekidan KG, Gebremeskel TG, Getacher L, Ghadirian F, Ghamari S-H, Ghasemi Nour M, Ghassemi F, Golechha M, Goleij P, Golinelli D, Gopalani SV, Guadie HA, Guan S-Y, Gudayu TW, Guimarães RA, Guled RA, Gupta R, Gupta K, Gupta VB, Gupta VK, Gyawali B, Haddadi R, Hadi NR, Haile TG, Hajibeygi R, Haj-Mirzaian A, Halwani R, Hamidi S, Hankey GJ, Hannan MA, Haque S, Harandi H, Harlianto NI, Hasan SMM, Hasan SS, Hasani H, Hassanipour S, Hassen MB, Haubold J, Hayat K, Heidari G, Heidari M, Hessami K, Hiraike Y, Holla R, Hossain S, Hossain MS, Hosseini M-S, Hosseinzadeh M, Hosseinzadeh H, Huang J, Huda MN, Hussain S, Huynh H-H, Hwang B-F, Ibitoye SE, Ikeda N, Ilic IM, Ilic MD, Inbaraj LR, Iqbal A, Islam SMS, Islam RM, Ismail NE, Iso H, Isola G, Itumalla R, Iwagami M, Iwu CCD, Iyamu IO, Iyasu AN, Jacob L, Jafarzadeh A, Jahrami H, Jain R, Jaja C, Jamalpoor Z, Jamshidi E, Janakiraman B, Jayanna K, Jayapal SK, Jayaram S, Jayawardena R, Jebai R, Jeong W, Jin Y, Jokar M, Jonas JB, Joseph N, Joseph A, Joshua CE, Joukar F, Jozwiak JJ, Kaambwa B, Kabir A, Kabthymer RH, Kadashetti V, Kahe F, Kalhor R, Kandel H, Karanth SD, Karaye IM, Karkhah S, Katoto PDMC, Kaur N, Kazemian S, Kebede SA, Khader YS, Khajuria H, Khalaji A, Khan MAB, Khan M, Khan A, Khanal S, Khatatbeh MM, Khater AM, Khateri S, khorashadizadeh F, Khubchandani J, Kibret BG, Kim MS, Kimokoti RW, Kisa A, Kivimäki M, Kolahi A-A, Komaki S, Kompani F, Koohestani HR, Korzh O, Kostev K, Kothari N, Koyanagi A, Krishan K, Krishnamoorthy Y, Kuate Defo B, Kuddus M, Kuddus MA, Kumar R, Kumar H, Kundu S, Kurniasari MD, Kuttikkattu A, La Vecchia C, Lallukka T, Larijani B, Larsson AO, Latief K, Lawal BK, Le TTT, Le TTB, Lee SWH, Lee M, Lee W-C, Lee PH, Lee S-w, Lee SW, Legesse SM, Lenzi J, Li Y, Li M-C, Lim SS, Lim L-L, Liu X, Liu C, Lo C-H, Lopes G, Lorkowski S, Lozano R, Lucchetti G, Maghazachi AA, Mahasha PW, Mahjoub S, Mahmoud MA, Mahmoudi R, Mahmoudimanesh M, Mai AT, Majeed A, Majma Sanaye P, Makris KC, Malhotra K, Malik AA, Malik I, Mallhi TH, Malta DC, Mamun AA, Mansouri B, Marateb HR, Mardi P, Martini S, Martorell M, Marzo RR, Masoudi R, Masoudi S, Mathews E, Maugeri A, Mazzaglia G, Mekonnen T, Meshkat M, Mestrovic T, Miao Jonasson J, Miazgowski T, Michalek IM, Minh LHN, Mini GK, Miranda JJ, Mirfakhraie R, Mirrakhimov EM, Mirza-Aghazadeh-Attari M, Misganaw A, Misgina KH, Mishra M, Moazen B, Mohamed NS, Mohammadi E, Mohammadi M, Mohammadian-Hafshejani A, Mohammadshahi M, Mohseni A, Mojiri-forushani H, Mokdad AH, Momtazmanesh S, Monasta L, Moniruzzaman M, Mons U, Montazeri F, Moodi Ghalibaf A, Moradi Y, Moradi M, Moradi Sarabi M, Morovatdar N, Morrison SD, Morze J, Mossialos E, Mostafavi E, Mueller UO, Mulita F, Mulita A, Murillo-Zamora E, Musa KI, Mwita JC, Nagaraju SP, Naghavi M, Nainu F, Nair TS, Najmuldeen HHR, Nangia V, Nargus S, Naser AY, Nassereldine H, Natto ZS, Nauman J, Nayak BP, Ndejjo R, Negash H, Negoi RI, Nguyen HTH, Nguyen DH, Nguyen PT, Nguyen VT, Nguyen HQ, Niazi RK, Nigatu YT, Ningrum DNA, Nizam MA, Nnyanzi LA, Noreen M, Noubiap JJ, Nzoputam OJ, Nzoputam CI, Oancea B, Odogwu NM, Odukoya OO, Ojha VA, Okati-Aliabad H, Okekunle AP, Okonji OC, Okwute PG, Olufadewa II, Onwujekwe OE, Ordak M, Ortiz A, Osuagwu UL, Oulhaj A, Owolabi MO, Padron-Monedero A, Padubidri JR, Palladino R, Panagiotakos D, Panda-Jonas S, Pandey A, Pandey A, Pandi-Perumal SR, Pantea Stoian AM, Pardhan S, Parekh T, Parekh U, Pasovic M, Patel J, Patel JR, Paudel U, Pepito VCF, Pereira M, Perico N, Perna S, Petcu I-R, Petermann-Rocha FE, Podder V, Postma MJ, Pourali G, Pourtaheri N, Prates EJS, Qadir MMF, Qattea I, Raee P, Rafique I, Rahimi M, Rahimifard M, Rahimi-Movaghar V, Rahman MO, Rahman MA, Rahman MHU, Rahman M, Rahman MM, Rahmani M, Rahmani S, Rahmanian V, Rahmawaty S, Rahnavard N, Rajbhandari B, Ram P, Ramazanu S, Rana J, Rancic N, Ranjha MMAN, Rao CR, Rapaka D, Rasali DP, Rashedi S, Rashedi V, Rashid AM, Rashidi M-M, Ratan ZA, Rawaf S, Rawal L, Redwan EMM, Remuzzi G, Rengasamy KRR, Renzaho AMN, Reyes LF, Rezaei N, Rezaei N, Rezaeian M, Rezazadeh H, Riahi SM, Rias YA, Riaz M, Ribeiro D, Rodrigues M, Rodriguez JAB, Roever L, Rohloff P, Roshandel G, Roustazadeh A, Rwegerera GM, Saad AMA, Saber-Ayad MM, Sabour S, Sabzmakan L, Saddik B, Sadeghi E, Saeed U, Saeedi Moghaddam S, Safi S, Safi SZ, Saghazadeh A, Saheb Sharif-Askari N, Saheb Sharif-Askari F, Sahebkar A, Sahoo SS, Sahoo H, Saif-Ur-Rahman KM, Sajid MR, Salahi S, Salahi S, Saleh MA, Salehi MA, Salomon JA, Sanabria J, Sanjeev RK, Sanmarchi F, Santric-Milicevic MM, Sarasmita MA, Sargazi S, Sathian B, Sathish T, Sawhney M, Schlaich MP, Schmidt MI, Schuermans A, Seidu A-A, Senthil Kumar N, Sepanlou SG, Sethi Y, Seylani A, Shabany M, Shafaghat T, Shafeghat M, Shafie M, Shah NS, Shahid S, Shaikh MA, Shanawaz M, Shannawaz M, Sharfaei S, Shashamo BB, Shiri R, Shittu A, Shivakumar KM, Shivalli S, Shobeiri P, Shokri F, Shuval K, Sibhat MM, Silva LMLR, Simpson CR, Singh JA, Singh P, Singh S, Siraj MS, Skryabina AA, Sohag AAM, Soleimani H, Solikhah S, Soltani-Zangbar MS, Somayaji R, Sorensen RJD, Starodubova AV, Sujata S, Suleman M, Sun J, Sundström J, Tabarés-Seisdedos R, Tabatabaei SM, Tabatabaeizadeh S-A, Tabish M, Taheri M, Taheri E, Taki E, Tamuzi JJLL, Tan K-K, Tat NY, Taye BT, Temesgen WA, Temsah M-H, Tesler R, Thangaraju P, Thankappan KR, Thapa R, Tharwat S, Thomas N, Ticoalu JHV, Tiyuri A, Tonelli M, Tovani-Palone MR, Trico D, Trihandini I, Tripathy JP, Tromans SJ, Tsegay GM, Tualeka AR, Tufa DG, Tyrovolas S, Ullah S, Upadhyay E, Vahabi SM, Vaithinathan AG, Valizadeh R, van Daalen KR, Vart P, Varthya SB, Vasankari TJ, Vaziri S, Verma Mv, Verras G-I, Vo DC, Wagaye B, Waheed Y, Wang Z, Wang Y, Wang C, Wang F, Wassie GT, Wei MYW, Weldemariam AH, Westerman R, Wickramasinghe ND, Wu Y, Wulandari RDWI, Xia J, Xiao H, Xu S, Xu X, Yada DY, Yang L, Yatsuya H, Yesiltepe M, Yi S, Yohannis HK, Yonemoto N, You Y, Zaman SB, Zamora N, Zare I, Zarea K, Zarrintan A, Zastrozhin MS, Zeru NG, Zhang Z-J, Zhong C, Zhou J, Zielińska M, Zikarg YT, Zodpey S, Zoladl M, Zou Z, Zumla A, Zuniga YMH, Magliano DJ, Murray CJL, Hay SI, Vos T. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet 2023;402:203-34.
pmid pmc
4. Maruvada P, Leone V, Kaplan LM, Chang EB. The human microbiome and obesity: moving beyond associations. Cell Host Microbe 2017;22:589-99.
crossref pmid
5. Asadi A, Shadab Mehr N, Mohamadi MH, Shokri F, Heidary M, Sadeghifard N, Khoshnood S. Obesity and gut-microbiota-brain axis: a narrative review. J Clin Lab Anal 2022;36:e24420.
crossref pmid pmc pdf
6. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 2021;19:55-71.
crossref pmid pdf
7. Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol 2021;27:3837-50.
crossref pmid pmc
8. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006;444:1022-3.
crossref pmid pdf
9. Yun Y, Kim HN, Kim SE, Heo SG, Chang Y, Ryu S, Shin H, Kim HL. Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort. BMC Microbiol 2017;17:151.
crossref pmid pmc pdf
10. Andoh A, Nishida A, Takahashi K, Inatomi O, Imaeda H, Bamba S, Kito K, Sugimoto M, Kobayashi T. Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a japanese population. J Clin Biochem Nutr 2016;59:65-70.
crossref pmid pmc
11. Kim MH, Yun KE, Kim J, Park E, Chang Y, Ryu S, Kim HL, Kim HN. Gut microbiota and metabolic health among overweight and obese individuals. Sci Rep 2020;10:19417.
crossref pmid pmc pdf
12. Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN, Bar N, Shilo S, Lador D, Vila AV, Zmora N, Pevsner-Fischer M, Israeli D, Kosower N, Malka G, Wolf BC, Avnit-Sagi T, Lotan-Pompan M, Weinberger A, Halpern Z, Carmi S, Fu J, Wijmenga C, Zhernakova A, Elinav E, Segal E. Environment dominates over host genetics in shaping human gut microbiota. Nature 2018;555:210-5.
pmid
13. Davis CD. The gut microbiome and its role in obesity. Nutr Today 2016;51:167-74.
crossref pmid pmc
14. Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA. Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications. Adv Nutr 2019;10:S17-30.
crossref pmid pmc
15. Rosas-Plaza S, Hernández-Terán A, Navarro-Díaz M, Escalante AE, Morales-Espinosa R, Cerritos R. Human gut microbiome across different lifestyles: from hunter-gatherers to urban populations. Front Microbiol 2022;13:843170.
crossref pmid pmc
16. Monda V, Villano I, Messina A, Valenzano A, Esposito T, Moscatelli F, Viggiano A, Cibelli G, Chieffi S, Monda M, Messina G. Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev 2017;2017:3831972.
crossref pmid pmc pdf
17. Dziewiecka H, Buttar HS, Kasperska A, Ostapiuk-Karolczuk J, Domagalska M, Cichoń J, Skarpańska-Stejnborn A. Physical activity induced alterations of gut microbiota in humans: a systematic review. BMC Sports Sci Med Rehabil 2022;14:122.
crossref pmid pmc pdf
18. Pérez-Prieto I, Plaza-Florido A, Ubago-Guisado E, Ortega FB, Altmäe S. Physical activity, sedentary behavior and microbiome: a systematic review and meta-analysis. J Sci Med Sport 2024;27:793-804.
crossref pmid
19. Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA, Holscher HD, Woods JA. Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc 2018;50:747-57.
crossref pmid
20. Sarmiento-Andrade Y, Suárez R, Quintero B, Garrochamba K, Chapela SP. Gut microbiota and obesity: new insights. Front Nutr 2022;9:1018212.
crossref pmid pmc
21. Torquati L, Gajanand T, Cox ER, Willis CRG, Zaugg J, Keating SE, Coombes JS. Effects of exercise intensity on gut microbiome composition and function in people with type 2 diabetes. Eur J Sport Sci 2023;23:530-41.
crossref pmid
22. Beals JW, Kayser BD, Smith GI, Schweitzer GG, Kirbach K, Kearney ML, Yoshino J, Rahman G, Knight R, Patterson BW, Klein S. Dietary weight loss-induced improvements in metabolic function are enhanced by exercise in people with obesity and prediabetes. Nat Metab 2023;5:1221-35.
crossref pmid pmc pdf
23. Dupuit M, Rance M, Morel C, Bouillon P, Boscaro A, Martin V, Vazeille E, Barnich N, Chassaing B, Boisseau N. Effect of concurrent training on body composition and gut microbiota in postmenopausal women with overweight or obesity. Med Sci Sports Exerc 2022;54:517-29.
crossref pmid
24. Wang Y, Chen J, Ni Y, Liu Y, Gao X, Tse MA, Panagiotou G, Xu A. Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study. Gut Microbes 2024;16:2416928.
crossref pmid pmc
25. Kern T, Blond MB, Hansen TH, Rosenkilde M, Quist JS, Gram AS, Ekstrøm CT, Hansen T, Stallknecht B. Structured exercise alters the gut microbiota in humans with overweight and obesity—a randomized controlled trial. Int J Obes (Lond) 2020;44:125-35.
crossref pmid pdf
26. Cullen JMA, Shahzad S, Kanaley JA, Ericsson AC, Dhillon J. The effects of 6 wk of resistance training on the gut microbiome and cardiometabolic health in young adults with overweight and obesity. J Appl Physiol (1985) 2024;136:349-61.
crossref pmid
27. Quiroga R, Nistal E, Estébanez B, Porras D, Juárez-Fernández M, Martínez-Flórez S, García-Mediavilla MV, de Paz JA, González-Gallego J, Sánchez-Campos S, Cuevas MJ. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. Exp Mol Med 2020;52:1048-61.
crossref pmid pmc pdf
28. Batitucci G, Almeida OG, De Martinis ECP, Solar I, Cintra DE, de Freitas EC. Intermittent fasting and high-intensity interval training do not alter gut microbiota composition in adult women with obesity. Am J Physiol Endocrinol Metab 2024;327:E241-57.
crossref pmid
29. Barnich N, Chassaing B, Rance M, Boisseau N. Effects of a cycling versus running HIIT program on fat mass loss and gut microbiota composition in men with overweight/obesity. Med Sci Sports Exerc 2024;56:839-50.
crossref pmid
30. Liu Y, Wang Y, Ni Y, Cheung CKY, Lam KSL, Wang Y, Xia Z, Ye D, Guo J, Tse MA, Panagiotou G, Xu A. Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention. Cell Metab 2020;31:77-91.
crossref pmid
31. Cullen JMA, Shahzad S, Dhillon J. A systematic review on the effects of exercise on gut microbial diversity, taxonomic composition, and microbial metabolites: identifying research gaps and future directions. Front Physiol 2023;14:1292673.
crossref pmid pmc
32. Ortiz-Alvarez L, Xu H, Martinez-Tellez B. Influence of exercise on the human gut microbiota of healthy adults: a systematic review. Clin Transl Gastroenterol 2020;11:e00126.
crossref pmid pmc
33. Chanda D, De D. Meta-analysis reveals obesity associated gut microbial alteration patterns and reproducible contributors of functional shift. Gut Microbes 2024;16:2304900.
crossref pmid pmc
34. Motiani KK, Collado MC, Eskelinen JJ, Virtanen KA, Löyttyniemi E, Salminen S, Nuutila P, Kalliokoski KK, Hannukainen JC. Exercise training modulates gut microbiota profile and improves endotoxemia. Med Sci Sports Exerc 2020;52:94-104.
crossref pmid pmc
35. Ozato N, Saito S, Yamaguchi T, Katashima M, Tokuda I, Sawada K, Katsuragi Y, Kakuta M, Imoto S, Ihara K, Nakaji S. Blautia genus associated with visceral fat accumulation in adults 20-76 years of age. NPJ Biofilms Microbiomes 2019;5:28.
crossref pmid pmc pdf
36. Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, Zhao J, Zhang H, Chen W. Blautia-a new functional genus with potential probiotic properties? Gut Microbes 2021;13:1-21.
crossref pmid pmc
37. Martín R, Rios-Covian D, Huillet E, Auger S, Khazaal S, Bermúdez-Humarán LG, Sokol H, Chatel JM, Langella P. Faecalibacterium: a bacterial genus with promising human health applications. FEMS Microbiol Rev 2023;47:fuad039.
pmid pmc
38. Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J 2017;11:841-52.
crossref pmid pmc pdf
39. Munukka E, Rintala A, Toivonen R, Nylund M, Yang B, Takanen A, Hänninen A, Vuopio J, Huovinen P, Jalkanen S, Pekkala S. Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. ISME J 2017;11:1667-79.
crossref pmid pmc pdf
40. Biddle A, Stewart L, Blanchard J, Leschine S. Untangling the genetic basis of fibrolytic specialization by lachnospiraceae and ruminococcaceae in diverse gut communities. Diversity 2013;5:627-40.
crossref
41. Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients 2020;12:1474.
crossref pmid pmc
42. Castaner O, Goday A, Park YM, Lee SH, Magkos F, Shiow STE, Schröder H. The gut microbiome profile in obesity: a systematic review. Int J Endocrinol 2018;2018:4095789.
crossref pmid pmc pdf
43. Muralidharan J, Moreno-Indias I, Bulló M, Lopez JV, Corella D, Castañer O, Vidal J, Atzeni A, Fernandez-García JC, Torres-Collado L, Fernández-Carrión R, Fito M, Olbeyra R, Gomez-Perez AM, Galiè S, Bernal-López MR, Martinez-Gonzalez MA, Salas-Salvadó J, Tinahones FJ. Effect on gut microbiota of a 1-y lifestyle intervention with Mediterranean diet compared with energy-reduced Mediterranean diet and physical activity promotion: PREDIMED-Plus study. Am J Clin Nutr 2021;114:1148-58.
crossref pmid pmc pdf
44. Wei S, Brejnrod AD, Trivedi U, Mortensen MS, Johansen MY, Karstoft K, Vaag AA, Ried-Larsen M, Sørensen SJ. Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a post-hoc analysis of a randomized clinical trial. Gut Microbes 2022;14:2005407.
crossref pmid pmc
45. Luo Y, Lan C, Li H, Ouyang Q, Kong F, Wu A, Ren Z, Tian G, Cai J, Yu B, He J, Wright AG. Rational consideration of akkermansia muciniphila targeting intestinal health: advantages and challenges. NPJ Biofilms Microbiomes 2022;8:81.
crossref pmid pmc pdf
46. Rodrigues VF, Elias-Oliveira J, Pereira Í S, Pereira JA, Barbosa SC, Machado MSG, Carlos D. Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes. Front Immunol 2022;13:934695.
crossref pmid pmc
47. Van Hul M, Cani PD. The gut microbiota in obesity and weight management: microbes as friends or foe? Nat Rev Endocrinol 2023;19:258-71.
crossref pmid pdf
48. Procházková N, Laursen MF, La Barbera G, Tsekitsidi E, Jørgensen MS, Rasmussen MA, Raes J, Licht TR, Dragsted LO, Roager HM. Gut physiology and environment explain variations in human gut microbiome composition and metabolism. Nat Microbiol 2024;9:3210-25.
crossref pmid pmc pdf
49. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT, Spector TD, Clark AG, Ley RE. Human genetics shape the gut microbiome. Cell 2014;159:789-99.
crossref pmid pmc


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
Korea University, 145 Anam-Ro, Seongbuk-gu,Seoul 02841, Republic of Korea
Tel: +82-10-7642-7895    Fax: +82-2-3290-2315    E-mail: jenbedit@gmail.com                

Copyright © 2026 by Korean Society for Exercise Nutrition.

Developed in M2PI

Close layer
prev next